U.S. biotech company Moderna has received approval from U.S. drug authorities for an anti-Covid-19 virus (Covidia) vaccine.
The U.S. Food and Drug Administration (FDA), in the midst of the second wave of a serious outbreak of the Covid-19 virus, on Thursday (Dec. 17, 2020) granted emergency approval to another vaccine developed by U.S. biotech company Moderna, after approving an anti-Covid-19 vaccine developed by Pfizer Pharmaceuticals in collaboration with German biotech company BioNtech. On Thursday (December 17, 2020), another vaccine developed by Moderna, a U.S. biotechnology company, was approved on an emergency basis. The Moderna vaccine is now the second anti-Covid-19 vaccine available in the United States.
According to a report by our RFI correspondent Loubna Anaki from New York on Friday (Dec. 18, 2020), the Food and Drug Administration has again approved a new vaccine to add to the massive anti-Covid-19 vaccination campaign launched in the United States earlier this week. The FDA believes that Modena’s anti-Covid-19 vaccine should be used as soon as possible. The final decision should be finalized by Friday. Six million doses of the vaccine will be sent across the United States by the end of this week, supplementing the three million doses of Pfizer vaccine that were distributed on Monday.
Modena vaccine has advantages
As far as U.S. authorities are concerned, the Modena vaccine has the advantage that it can be shipped over a wider geographical area, reaching remote and isolated areas. Because it can be stored at normal temperatures, in contrast to Pfizer’s vaccine, which needs to be kept at minus 70 degrees Celsius (-70°C). With these two approved anti-Covid-19 vaccines, Americans will be able to increase production rates and ensure future supply needs. Currently, priority is given to supplying health care workers and nursing homes.
The anti-Covid-19 vaccine developed by U.S. biotech company Moderna.
Also according to AFP news from Washington on Thursday (Dec. 17, 2020), a U.S. panel of experts voted 20 to none and one abstention the same day to recommend emergency approval of Massachusetts-based Moderna Biotech’s anti-COVID-19 virus vaccine, paving the way for shipments of six million doses to begin as early as the end of this week. The United States may be the first country in the world to approve the use of Moderna’s anti-Covid-19 virus vaccine.
Recent Comments